/ Unknown statusNot Applicable A Scientific & Clinical Review of Minimal Stimulation Protocol Using AROMEK (Letrozole) and Follitrope (Recombinant FSH)Combined With INVOCell(Intravaginal Culturing) - Effectiveness as Low Cost IVF
The purpose of this study to evaluate a low cost minimal stimulation protocol combined with Intravaginal Culturing, to make IVF affordable and available across the large infertile/subfertile population
100 Clinical Results associated with Galaxy Pharma Private Limited
0 Patents (Medical) associated with Galaxy Pharma Private Limited
100 Deals associated with Galaxy Pharma Private Limited
100 Translational Medicine associated with Galaxy Pharma Private Limited